StonvexLoading…
StonvexStonvexStonvexCore line items from HRMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $868.45M | $714.73M | $582.02M | $437.86M |
Operating Income | $208.47M | $190.83M | $192.03M | $120.19M |
Net Income | $158.69M | $145.49M | $128.85M | $181.47M |
EPS (Diluted) | $2.71 | $2.51 | $2.13 | $2.97 |
Total Assets | $1.27B | $999.20M | $811.45M | $673.87M |
Total Liabilities | $401.41M | $340.05M | $344.46M | $271.03M |
Cash & Equivalents | $752.50M | $453.00M | $311.66M | $243.78M |
Free Cash Flow OCF − CapEx | $347.89M | $218.67M | $219.07M | $144.29M |
Shares Outstanding | 57.73M | 57.14M | 56.77M | 59.62M |